Drug delivery approaches for HuR-targeted therapy for lung cancer

R Raguraman, S Shanmugarama, M Mehta… - Advanced drug delivery …, 2022 - Elsevier
Lung cancer (LC) is often diagnosed at an advanced stage and conventional treatments for
disease management have limitations associated with them. Novel therapeutic targets are …

The RNA-binding protein HuR in human cancer: A friend or foe?

X Wu, L Xu - Advanced drug delivery reviews, 2022 - Elsevier
The RNA-binding proteins (RBPs) are critical trans factors that associate with specific cis
elements present in mRNAs whose stability and translation are subject to regulation. The …

Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein …

R Muralidharan, A Babu, N Amreddy… - Molecular cancer …, 2017 - AACR
Selective downregulation of the human antigen R (HuR) protein by siRNA may provide a
powerful approach for treating lung cancer. To this end, we investigated the efficacy of …

Targeting the RNA-binding protein HuR in cancer

JM Finan, TL Sutton, DA Dixon, JR Brody - Cancer Research, 2023 - AACR
The RNA-binding protein human antigen R (HuR) is a well-established regulator of gene
expression at the posttranscriptional level. Its dysregulation has been implicated in various …

HuR as a molecular target for cancer therapeutics and immune-related disorders

M Majumder, P Chakraborty, S Mohan… - Advanced drug delivery …, 2022 - Elsevier
The control of eukaryotic gene expression occurs at multiple levels, from transcription to
messenger RNA processing, transport, localization, turnover, and translation. RNA-binding …

The RNA binding protein HuR: a promising drug target for anticancer therapy

M Wu, CWS Tong, W Yan, KKW To… - Current cancer drug …, 2019 - ingentaconnect.com
The stability of mRNA is one of the key factors governing the regulation of eukaryotic gene
expression and function. Human antigen R (HuR) is an RNA-binding protein that regulates …

HuR-targeted agents: an insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models

G Assoni, V La Pietra, R Digilio, C Ciani… - Advanced Drug Delivery …, 2022 - Elsevier
Abstract The Human antigen R (HuR) protein is an RNA-binding protein, ubiquitously
expressed in human tissues, that orchestrates target RNA maturation and processing both in …

HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells

R Muralidharan, M Mehta, R Ahmed, S Roy, L Xu… - Scientific reports, 2017 - nature.com
Human antigen (Hu) R is an RNA-binding protein whose overexpression in human cancer
correlates with aggressive disease, drug resistance, and poor prognosis. HuR inhibition has …

Understanding and targeting the disease‐related RNA binding protein human antigen R (HuR)

CW Schultz, R Preet, T Dhir, DA Dixon… - Wiley Interdisciplinary …, 2020 - Wiley Online Library
Altered gene expression is a characteristic feature of many disease states such as
tumorigenesis, and in most cancers, it facilitates cancer cell survival and adaptation …

Small molecules targeting the RNA-binding protein HuR inhibit tumor growth in xenografts

X Wu, R Ramesh, J Wang, Y Zheng… - Journal of medicinal …, 2023 - ACS Publications
The RNA-binding protein Hu antigen R (HuR) is a post-transcriptional regulator critical in
several types of diseases, including cancer, making it a promising therapeutic target. We …